Recent Finacing
Recent Raise
AM-Pharma is a clinical-stage biopharmaceutical company developing recAP, a cGMP-manufactured recombinant human alkaline phosphatase (injectable and oral), advancing Phase III trials for sepsis-associated AKI and other indications.
